DEBORAH HEWLETT: Open Payments
NPI 1619488988 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,001 in 38 payments from 14 companies in 2025. Trend: 2023 $1,911 · 2024 $1,870 · 2025 $1,001
Food & beverage: $1,001
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 2 | $189 |
| Organon LLC | 6 | $122 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $104 |
| LEO Pharma Inc. | 4 | $100 |
| Novartis Pharmaceuticals Corporation | 2 | $96 |
| PFIZER INC. | 4 | $78 |
| Galderma Laboratories, L.P. | 4 | $76 |
| Incyte Corporation | 3 | $63 |
| Janssen Biotech, Inc. | 2 | $45 |
| UCB, Inc. | 1 | $38 |
Products named: Zoryve, CIBINQO, NEMLUVIO, ADBRY, OPZELURA, ILUMYA, VTAMA, TREMFYA.
Industry payments across MD — which companies pay providers there.
